Archford Capital Strategies, LLC Novartis Ag Transaction History

Archford Capital Strategies, LLC

$592 Million
Q1 2024

A detailed history of Archford Capital Strategies, LLC transactions in Novartis Ag stock. As of the latest transaction made, Archford Capital Strategies, LLC holds 14,073 shares of NVS stock, worth $1.52 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

14,073

Previous 13,716 2.6%

Holding current value

$1.52 Million

Previous $1.38 Million 1.66%

% of portfolio

0.23%

Previous 0.25%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$95.27 - $108.47 $34,011 - $38,723	357 Added 2.6%	14,073 $1.36 Million
Q4 2023 Jan 12, 2024	SELL	$92.27 - $101.54 $40,967 - $45,083	-444 Reduced 3.14%	13,716 $1.38 Million
Q3 2023 Oct 27, 2023	SELL	$94.73 - $105.13 $31,639 - $35,113	-334 Reduced 2.3%	14,160 $1.44 Million
Q2 2023 Aug 02, 2023	SELL	$92.52 - $104.91 $20,076 - $22,765	-217 Reduced 1.48%	14,494 $1.46 Million
Q1 2023 Apr 18, 2023	BUY	$80.03 - $92.81 $24,089 - $27,935	301 Added 2.09%	14,711 $1.35 Million

Q4 2022 Jan 26, 2023	BUY	$75.55 - $92.52 $20,322 - $24,887	269 Added 1.9%	14,410 $0
Q3 2022 Oct 17, 2022	BUY	$74.61 - $87.26 $27,829 - $32,547	373 Added 2.71%	14,141 $1.08 Million
Q2 2022 Jul 12, 2022	BUY	$80.52 - $93.75 $1.11 Million - $1.29 Million	13,768 New	13,768 $1.16 Million
Q1 2022 Apr 18, 2022	SELL	$80.11 - $90.62 $663,230 - $750,242	-8,279 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$79.7 - $88.13 $24,707 - $27,320	310 Added 3.89%	8,279 $724,000
Q3 2021 Oct 14, 2021	BUY	$81.78 - $95.14 $52,911 - $61,555	647 Added 8.84%	7,969 $652,000
Q2 2021 Jul 23, 2021	BUY	$85.24 - $94.15 $35,118 - $38,789	412 Added 5.96%	7,322 $668,000
Q1 2021 Apr 26, 2021	BUY	$83.5 - $98.47 $30,060 - $35,449	360 Added 5.5%	6,910 $603,000
Q4 2020 Jan 19, 2021	BUY	$78.07 - $94.43 $15,379 - $18,602	197 Added 3.1%	6,550 $616,000
Q3 2020 Oct 19, 2020	BUY	$82.14 - $91.0 $36,798 - $40,768	448 Added 7.59%	6,353 $552,000
Q2 2020 Jul 24, 2020	BUY	$80.93 - $91.1 $141,303 - $159,060	1,746 Added 41.98%	5,905 $516,000
Q1 2020 Apr 29, 2020	BUY	$70.67 - $99.01 $78,373 - $109,802	1,109 Added 36.36%	4,159 $343,000
Q4 2019 Jan 15, 2020	BUY	$84.35 - $95.37 $18,388 - $20,790	218 Added 7.7%	3,050 $289,000
Q3 2019 Oct 23, 2019	BUY	$85.54 - $94.26 $12,317 - $13,573	144 Added 5.36%	2,832 $246,000
Q2 2019 Jul 18, 2019	BUY	$75.4 - $92.8 $18,171 - $22,364	241 Added 9.85%	2,688 $245,000
Q1 2019 May 13, 2019	BUY	$75.32 - $86.15 $9,866 - $11,285	131 Added 5.66%	2,447 $235,000
Q4 2018 Feb 13, 2019	BUY	$73.66 - $82.02 $39,334 - $43,798	534 Added 29.97%	2,316 $199,000
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $10,978 - $12,698	-164 Reduced 8.43%	1,782 $154,000
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $11,099 - $12,544	171 Added 9.63%	1,946 $147,000
Q1 2018 May 14, 2018	SELL	$70.39 - $84.15 $643,786 - $769,635	-9,146 Reduced 83.75%	1,775 $149,000
Q2 2017 Aug 18, 2017	BUY	N/A	10,921	10,921 $1.04 Million

Others Institutions Holding NVS

# of Institutions

1,350

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $232B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Archford Capital Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Archford Capital Strategies, LLC with notifications on news.

Account

Archford Capital Strategies, LLC Novartis Ag Transaction History